Lobectomy versus sublobar resection for stage I (T1-T2aN0M0) small cell lung cancer: A SEER population-based propensity score matching analysis.

Ning ZhouLingqi YangBo ZhangShuai ZhuHuandong HuoJinling HeLingling ZuZuoqing SongSong Xu

Published in: Cancer medicine (2022)

Surgery plus adjuvant therapy confers a better survival benefit than surgery only for stage I SCLC patients. However, as far as the range of surgical resection is concerned, sublobar resection may be non-inferior to lobectomy regarding OS. Our study could conduce to the development of optimal therapeutic strategies for stage I SCLC patients. Further validation is warranted in larger retrospective and prospective cohort studies.

Keyphrases

end stage renal disease
small cell lung cancer
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis
atrial fibrillation
patient reported
data analysis